IntellIoT is a Pan-European Research and Innovation project supported by the European Commission. It is focused on intelligent, autonomous, and human-centered healthcare solutions. With the help of Artificial Intelligence (AI) and Internet of Things (IoT) technologies, patients with cardiovascular diseases will be treated remotely. The 3-year project also aims to support the rollout of IoT technologies in the manufacturing and agricultural sectors.
The project fosters the development of humanized IoT and AI devices and systems. It comprises a consortium of 13 partners spread across 9 countries. The initiative aims to facilitate a competitive ecosystem and to strengthen the European market in finding solutions applicable in healthcare, agriculture and manufacturing.
The Covid-19 crisis has posed unprecedented demands on healthcare systems worldwide, highlighting like never before the need to develop new, human-centered and autonomous technologies that can dramatically optimize patient-management and treatment. The use of biometric sensors and remote health assistance allows close monitoring without the need for face-to-face consultation or physical hospital visits. Activity trackers and health monitoring devices are instrumental for the early detection of the disease or possible infection, right up to the point where a virus infection starts to spread.
According to the team, allowing remote care can prevent unnecessary hospitalizations, relieve pressure on hospitals, reduce healthcare costs and improve the quality of patient care. New IoT applications will enable autonomous health monitoring and interventions by carefully preserving the privacy and security of patients’ data and providing trust assurance.
“By applying AI in a way that improves decision-making for healthcare providers, IntellIoT has the potential to help capture and make sense of each patient’ s data throughout their unique care pathway, ultimately supporting the quadruple aim: an improved experience for staff and patients, better health outcomes and a lower cost of care,’ said Anca Bucur, Senior Researcher at Philips.
Over the course of the next three years, IntellIoT will leverage technologies in 5G, cybersecurity, distributed computing, augmented reality and tactile internet. The project’ s focus is to empower healthcare professionals and establishments to work more efficiently and with greater insight, and to place patients’ needs and their wellbeing at the forefront.
IntellIoT will hold two open calls geared towards enabling startups and SMEs to build applications, services and extensions on the project’ s framework in three concrete use cases: 1) healthcare, 2) agriculture and 3) manufacturing. SMEs and startups will receive up to â‚¬150,000 to execute pilot projects alongside the 13 consortia partners, in order to apply the IntellIoT technology, improve their products and services, and create new jobs.
Championing the development of integrated, distributed, human-centered and trustworthy IoT environments, IntellIoT is made up of 13 partners, including the University General Hospital of Heraklion, which has been put to the test throughout the pandemic. In the special healthcare project, the University General Hospital of Heraklion will work with experts from health technology company Philips, with the aim of developing AI algorithms that support existing diagnostic healthcare devices and sensors, and to evaluate new tech architectures with end-users, such as patients and medical experts in realistic environments at the hospital. Through enabling new technologies, IntellIoT can help furnish the hospitals of the future with intelligent devices that autonomously conduct health monitoring and interventions, and analyse large swathes of data while relieving pressure on otherwise overloaded healthcare systems.
You can find more information on the project’s website.